DANAHER CORPORATION

Lobbying for DANAHER CORPORATION · health care products developer and manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $230,000.00 expenses · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.